Dr. Lal Path Labs Quarterly Results for Trading Insights
In Mar 2026, Dr. Lal Path Labs (LALPATHLAB) reported revenue ₹727 Cr and net profit ₹132 Cr — revenue +15.8% YoY. Analyse LALPATHLAB FII DII holdings to track promoter, FII and institutional holdings.
LALPATHLAB Quarterly Results — Revenue, Profit & EPS Highlights
Dr. Lal Path Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Dr. Lal Path Labs stock price NSE.
- Revenue of ₹727 Cr in Mar 2026 (-12.4% vs Jun 2026, +15.8% vs Mar 2025)
- Net Profit of ₹132 Cr in Mar 2026 (-22.8% vs Jun 2026, -15.4% vs Mar 2025)
- EBITDA of ₹211 Cr in Mar 2026 (-24.4% vs Jun 2026)
- Operating Margin of 27.0% in Mar 2026 (-4.0pp vs Jun 2026)
- Earnings Per Share of ₹7.86 in Mar 2026 (-22.6% vs Jun 2026)
Dr. Lal Path Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS
LALPATHLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 727 | 830 | 755 | 628 | 698 | -12.4% | 15.8% |
| Net Profit (₹ Cr) | 132 | 171 | 152 | 156 | 134 | - | - |
| EBITDA (₹ Cr) | 211 | 279 | 249 | 195 | 220 | - | - |
| EPS (₹) | 7.86 | 10.15 | 18.05 | 18.57 | 15.88 | - | - |
| Operating Margin (%) | 27.0% | 31.0% | 31.0% | 28.0% | 29.0% | - | - |
LALPATHLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Dr. Lal Path Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View LALPATHLAB 52-week performance for the annual high/low range and current price position.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
LALPATHLAB vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Dr. Lal Path Labs latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹128,608.19 Cr | 8944.5 | 6,660 | 551 | -6.3% | - | 8.3% | 242.9 |
|
Max Healthcare Inst…
Mar 2026 |
₹100,244.11 Cr | 1049.3 | 2,191 | 342 | -9.0% | - | 15.6% | 298.1 |
|
Fortis Healthcare
Mar 2026 |
₹67,025.18 Cr | 886.0 | 2,375 | 271 | -7.7% | - | 11.4% | 251.7 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 755.1 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 277.6 |
|
Narayana Hrudayalaya
Mar 2026 |
₹38,902.12 Cr | 1928.5 | 2,623 | 224 | -3.5% | - | 8.5% | 175.0 |
All amounts in ₹ Crores